"Slovakia Pharmaceuticals & Healthcare Report Q3 2012" Now Available at Fast Market Research
BMI View: Despite the formation of new government in Slovakia, our contractionary outlook for the pharmaceutical market has been maintained as key drug policy reforms passed by the legislature in September 2011 prior to the downfall of the previous government will still be in effect. Following the appointment of Zuzana Zvolenska as the new minister of health in April, there has been no sign she will significantly alter from this course, which is bad news for drugmakers.
View full press release